Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension

Abstract

Despite a similar afterload, RV function is more severely affected in mutation carriers than in noncarriers. However, these differences cannot be explained by a differential transforming growth factor β, bone morphogenetic protein receptor II signaling, or cardiac adaptation.